The possible role of levamisole in illicit cocaine preparations

Journal of Analytical Toxicology

Volumn 33, Issue 9, 2009, Pages 620-622

  Raymon, Lionel P ^a   Isenschmid, Daniel S ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Office of the Wayne County Medical Examiner   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ADRENALIN; COCAINE; DOPAMINE; GLUTAMIC ACID; LEVAMISOLE; NICOTINIC RECEPTOR; NORADRENALIN; ANTHELMINTIC AGENT; CENTRAL STIMULANT AGENT;

AGRANULOCYTOSIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EUPHORIA; HEART ARRHYTHMIA; HUMAN; HYPOTHALAMUS; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PARASYMPATHETIC GANGLION; POSTGANGLIONIC NERVE; SYMPATHETIC GANGLION; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; VENTRAL TEGMENTUM; CHEMISTRY; COCAINE DEPENDENCE; DRUG CONTAMINATION; DRUG EFFECT; DRUG INTERACTION; LETTER;

ANTHELMINTICS; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DRUG CONTAMINATION; DRUG INTERACTIONS; HUMANS; LEVAMISOLE;

EID: 74549117199     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.9.620     Document Type: Article

References (13)

1. J.F. Casale, E.M. Corbeil, and P.A. Hayes. Identification of levamisole impurities found in illicit cocaine exhibits. Microgram J. 6: 82-89 (2008).
2. P.M. Vanhoutte, J.M. Van Nueten, T.J. Verbeuren, and P.M. Laduron. Differential effects of the isomers of tetramisole on adrenergic neurotransmission in cutaneous veins of dog. J. Pharmacol. Exp. Ther. 200: 127-140 (1977).
3. J. Brugmans, R. Van Lommel, and F. Baro. Clinical aspects of tetramisole, an anthelminthic with antidepressant activity. Psychopharmacology suppl. 25: 85 (1972).
4. G. DiChiara and A. Imperato. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278 (1988).
5. G.F. Koob and F.E. Bloom. Cellular and molecular mechanisms of drug dependence. Science 242: 715-723 (1988).
6. A. Reid and A. Lingford-Hughes. Neuropharmacology of addiction. Psychiatry 5: 449-454 (2006).
7. S. Spector, I. Munjal, and D.E. Schmidt. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology 19: 417-427 (1998).
8. B.S. Koppel. Toxins and drugs reported to induce seizures. http://professionals.epilepsy.com/page/table-drugs-induce.html, April 2009.
9. D. Rayes, M.J. De Rosa, M. Bartos, and C. Bouzat. Molecular basis of the differential sensitivity of nematode and mammalian muscle to the anthelmintic agent levamisole. J. Biol. Chem. 279: 36372-36381 (2004).
10. M.M Levandoski, B. Piket, and J. Chang. The antihelminthic levamisole is an allosteric modulator of human neuronal nicotinic acetylcholine receptors. Eur. J. Pharmacol. (471): 9-20 (2003).
11. N.Y. Zhu, D.F. LeGatt, and A.R. Turner. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann. Intern. Med. 150: 287-289 (2009).
12. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 8th ed. Biomedical Publications, Foster City, CA, 2008, pp 349-355.
13. E. Kouassi, G. Callé, L. Léry, L. Larivière and M. Vézina. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm. Drug Dispos. 7: 71-89 (1986).